The US Food and Drug Administration. (FDA) warned today about the growing use of electronic cigarettes among young people, which can even lead to the need for drug therapies to treat that addiction.
FDA Commissioner Scott Gottlieb said at a public hearing that while the use of electronic cigarettes soars, consumption of traditional cigarettes is declining.
"A few years ago, it would have been incredible to me if we were here today discussing the potential of drug therapy to help young people quit their addiction," said Gottlieb, in remarks reproduced by The Hill.
The official said that while in recent years seemed ready to end "one of the most pernicious public challenges" of this time, referring to the deaths and diseases caused by snuff, today the potential of therapies for that the young vaporizers leave nicotine.
As vaporeo is known the action of aspirating and firing the steam of electronic cigarettes.
"Unfortunately, this progress is being weakened, even overshadowed by the recent dramatic increase in vaporeo in young people," he added.
According to Gottlieb, the availability and popularity of electronic cigarettes of the JUUL Labs brand, widely known among the youngest, has led to a doubled delivery between 2017 and 2018.
"Unfortunately, data from the Youth Tobacco Use Survey of 2018 confirm that the use of electronic cigarettes by young people has become an epidemic," he said.
And, the commissioner explained, between 2017 and 2018 there has been a 78% increase in the use of electronic cigarettes among high school students, and 48% among middle school students.
The leader of the FDA pointed out that the number of secondary and middle school students who regularly use the electronic cigarette is 3.6 million, which represents an increase of around 1.5 million students over the previous year.